Vir Biotechnology VIR
NASDAQ VIR
$10.65 +0.14 (+1.33%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Share-based Compensation (2018 - 2026)

Updated

Vir Biotechnology's Share-based Compensation was $12.39 million in Q2 2026, down 0.5% from $12.45 million a year earlier but up 2.5% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Share-based Compensation (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vir Biotechnology's Share-based Compensation was $47.04 million through Jun 30, 2026, down 20.3% year-over-year; for FY2025, it was $49.07 million, down 37.5% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 12.2% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $78.46 million in FY2024 (-29.5%), $111.32 million in FY2023 (+9.0%), $102.08 million in FY2022 (+21.8%) and $83.78 million in FY2021 (+203.6%).
  • Quarterly Share-based Compensation has moved between $11.21 million (Q4 2025) and $30.62 million (Q2 2023) over five years.
  • Compared with a year earlier, Share-based Compensation has declined for ten straight quarters, with an average decline of 30.3% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q3 2021 (growth of 167.4%); the worst was Q4 2024 (a decline of 44.0%).
  • Per Business Quant data, VIR's Share-based Compensation in the three quarters before Q2 2026 was $12.09 million (Q1 2026), $11.21 million (Q4 2025) and $11.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn 12.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.39 Mn
Mar 31, 2026 12.09 Mn
Dec 31, 2025 11.21 Mn
Sep 30, 2025 11.36 Mn
Jun 30, 2025 12.45 Mn
Mar 31, 2025 14.06 Mn
Dec 31, 2024 15.84 Mn
Sep 30, 2024 16.70 Mn
Jun 30, 2024 22.16 Mn
Mar 31, 2024 23.76 Mn
Dec 31, 2023 28.27 Mn
Sep 30, 2023 26.94 Mn
Jun 30, 2023 30.62 Mn
Mar 31, 2023 25.48 Mn
Dec 31, 2022 24.87 Mn
Sep 30, 2022 24.81 Mn
Jun 30, 2022 27.10 Mn
Mar 31, 2022 25.30 Mn
Dec 31, 2021 24.37 Mn
Sep 30, 2021 22.94 Mn
API Access

Vir Biotechnology Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VIR&period=max&api_key=YOUR_API_KEY